Jim Ricchiuti: With the litigation uncertainty behind you and the growing cash position. What I’m wondering is you guys have periodically looked at MNA as a means of accelerating parts of the business, and parts of the business. The Voyantic acquisition sounds like it was a nice acquisition for you. Small, but I think provides some benefits. I’m wondering if we might see a pickup at all or if you’re looking at opportunities that might accelerate the growth in some of the newer markets.
Chris Diorio: Yes, Jim, I’ll do my best to answer that question. Obviously, I can’t speak to any particular opportunities or anything that might be coming our way. Voyantic was an opportunity for us because what they offered was well aligned with our platform. Essentially, they’re at the front end of the inlay manufacturing or inlay testing, quality assurance, and some data services around the inlays, which of course, use our ICs and leverage our ICs for the inlay. So it was a natural addition to our platform that I think will stand us in good stead going forward. We are always open to other areas that strengthen and augment our platform. And if someone was to come along, we’d be interested. And we keep our eyes open all the time.
I don’t think the additional cash is going to say, oh, we’re actually going to. It’s going to make a huge difference either way. It’s really identifying an opportunity that makes sense for us as a company. You know, the additional cash is nice because it’s easier for us to finance it. But the key thing is we see an opportunity that’s good for us, we’ll pursue it, and absent that, we won’t.
Jim Ricchiuti: Okay. And one final question, if I may just Cary. I think you alluded to the M800 volume still being relatively small, but is there any way, I think you touched on this at the Investor Day, as but has your thinking around the impact on gross margins as that scales, has that changed at all? And maybe you could just remind us of the impact as it becomes a bigger part of the overall volume.
Cary Baker: Thanks, Jim. So the M800 benefits from a lower cost basis, and that lower cost basis will translate into approximately 300 basis points of gross margin accretion as the M800 ramps and becomes the volume runner in our business. Now, an endpoint IC ramp, when we typically launch a new IC takes multiple years to achieve, call it volume running status. We’re certainly pleased with where we are, and as Chris alluded to in his prepared remarks, where the M800 is ramping into Q2, but the volumes are still small and the impact on gross margin is not visible at this point. We’re the early days of the ramp. It’s really too hard to project a precise timing of that ramp. We’re encouraged with where we are, and we’ll keep you up to date as we progress in that ramp and throughout this year.
Jim Ricchiuti: Okay, thanks a lot.
Cary Baker: Thank you.
Operator: Thank you. [Operator Instructions] I’m seeing no further questions, this concludes our question-and-answer session. I would like to turn the conference back over to Co-Founder and CEO, Chris Diorio for any closing remarks.
Chris Diorio: Thank you, MJ. Thank you very much. And I’d like to thank all who were on the call today for joining us. Thank you for your ongoing support. Bye-bye.
Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect your lines.
